Your browser doesn't support javascript.
loading
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
Marth, Christian; Vergote, Ignace; Scambia, Giovanni; Oberaigner, Willi; Clamp, Andrew; Berger, Regina; Kurzeder, Christian; Colombo, Nicoletta; Vuylsteke, Peter; Lorusso, Domenica; Hall, Marcia; Renard, Vincent; Pignata, Sandro; Kristeleit, Rebecca; Altintas, Sevilay; Rustin, Gordon; Wenham, Robert M; Mirza, Mansoor Raza; Fong, Peter C; Oza, Amit; Monk, Bradley J; Ma, Haijun; Vogl, Florian D; Bach, Bruce A.
Afiliação
  • Marth C; AGO-Austria and Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: Christian.MARTH@tirol-kliniken.at.
  • Vergote I; BGOG and Department of Obstetrics and Gynecology, University Hospital Leuven, Leuven Cancer Institute, KU Leuven, Belgium.
  • Scambia G; MITO and Dipartimento per la Tutela della Salute della Donna e della Vita Nascente del Bambino e Adolescente, Policlinico Universitario Agostino Gemelli, Roma, Italy.
  • Oberaigner W; AGO-Austria and Department of Clinical Epidemiology of the Tirol Kliniken Ltd., Cancer Registry of Tyrol, Innsbruck, Austria.
  • Clamp A; Department of Medical Oncology, Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • Berger R; AGO-Austria and Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Kurzeder C; AGO-Study Group and Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte/Evang. Huyssens Stiftung/Knappschaft GmbH, Essen, Germany.
  • Colombo N; MANGO and Istituto Europeo di Oncologia and Università Milano Bicocca, Milano, Italy.
  • Vuylsteke P; BGOG and Department of Medical Oncology, CHU Université Catholique de Louvain, Site Sainte Elisabeth, Namur, Belgium.
  • Lorusso D; MITO and Unità di Ginecologia Oncologica, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Hall M; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Renard V; BGOG and Department of Oncology, AZ St. Lucas, Ghent, Belgium.
  • Pignata S; MITO and Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale" IRCCS, Naples, Italy.
  • Kristeleit R; Department of Medical Oncology, University College London Cancer Institute, London, UK.
  • Altintas S; BGOG and Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.
  • Rustin G; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Wenham RM; Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Mirza MR; NSGO & Department of Oncology, Rigshospitalet, København, Denmark.
  • Fong PC; Medical Oncology Department, Auckland City Hospital, Auckland, New Zealand.
  • Oza A; Department of Medicine, Princess Margaret Hospital, University of Toronto, ON, Canada.
  • Monk BJ; Department of Obstetrics and Gynecology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
  • Ma H; Global Development Oncology, Amgen Inc., Thousand Oaks, CA, USA.
  • Vogl FD; Global Development Oncology, Amgen Inc., Thousand Oaks, CA, USA.
  • Bach BA; Global Development Oncology, Amgen Inc., Thousand Oaks, CA, USA.
Eur J Cancer ; 70: 111-121, 2017 01.
Article em En | MEDLINE | ID: mdl-27914241
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2017 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2017 Tipo de documento: Article País de publicação: Reino Unido